Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adaptogenic response modulation refers to the process by which adaptogenic compounds (mainly from plants) enhance an organism’s non-specific resistance to stress, usually by modulating the physiological network that coordinates the stress response. These effects are typically mediated by modifying hormone levels (especially cortisol via partial agonism at glucocorticoid receptors), activating regulatory pathways in the hypothalamic–pituitary–adrenal (HPA) axis, inducing expression of protective proteins such as Hsp70/Hsp72, and influencing cellular energy states (e.g., normalizing ATP production). Adaptogens do not act on a specific receptor or molecular target but instead operate as complex metabolic and stress-response modulators, which differentiates them from drugs targeting defined biomolecules or receptors.
Multi-target network modulation, Partial agonism at glucocorticoid receptors, Regulation of hypothalamic–pituitary–adrenal (HPA) axis, Increase of heat shock protein expression (Hsp70/Hsp72), Metabolic normalization (e.g., restoring ATP levels), Gene expression modulation (e.g., FOXO)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adaptogenic response modulation.